SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-029128
Filing Date
2022-08-11
Accepted
2022-08-11 16:16:25
Documents
14
Period of Report
2022-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-8k_20220811.htm   iXBRL 8-K 39814
2 EX-99.1 hsto-ex991_6.htm EX-99.1 309892
3 GRAPHIC gdkycieagypp000001.jpg GRAPHIC 2088
  Complete submission text file 0001564590-22-029128.txt   496864

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hsto-20220811.xsd EX-101.SCH 5601
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20220811_lab.xml EX-101.LAB 19324
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20220811_pre.xml EX-101.PRE 11495
8 EXTRACTED XBRL INSTANCE DOCUMENT hsto-8k_20220811_htm.xml XML 3547
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 221156100
SIC: 2834 Pharmaceutical Preparations